A Phase I Open-Label, Dose-Escalation, Multi-Institutional Trial of Injection with an -Attenuated Adenovirus, ONYX-015, into the Peritumoral Region of Recurrent Malignant Gliomas, in the Adjuvant Setting
CHIOCCA, E, ABBED, K, TATTER, S, LOUIS, D, HOCHBERG, F, BARKER, F, KRACHER, J, GROSSMAN, S, FISHER, J, CARSON, KVolume:
10
Language:
english
Journal:
Molecular Therapy
DOI:
10.1016/j.ymthe.2004.07.021
Date:
November, 2004
File:
PDF, 417 KB
english, 2004